Neuropsychopharmacology Reports
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.9 | Q3 | 37.2% | 0.561 | Q2 | 65.3% |
| 2024 | 1.5 | Q3 | 30.9% | 0.602 | Q2 | 68.5% |
| 2023 | 2.0 | Q3 | 44.9% | 0.660 | Q2 | 73.9% |
| 2022 | 2.5 | 48.4% | 0.651 | Q2 | 74.5% | |
| 2021 | — | — | 0.579 | Q2 | 71.7% | |
| 2020 | — | — | 0.661 | Q2 | 74.6% | |
| 2019 | — | — | 0.334 | Q3 | 55.8% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2574-173X
country
UScoverage
2018-2026